Deroy & Devereaux Private Investment Counsel’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-875
Closed -$248K 144
2020
Q3
$248K Hold
875
0.03% 131
2020
Q2
$234K Hold
875
0.03% 129
2020
Q1
$277K Hold
875
0.04% 116
2019
Q4
$260K Hold
875
0.02% 123
2019
Q3
$204K Sell
875
-125
-13% -$29.1K 0.02% 143
2019
Q2
$234K Hold
1,000
0.02% 129
2019
Q1
$236K Hold
1,000
0.02% 137
2018
Q4
$301K Hold
1,000
0.03% 123
2018
Q3
$353K Hold
1,000
0.04% 127
2018
Q2
$290K Hold
1,000
0.03% 135
2018
Q1
$274K Hold
1,000
0.03% 141
2017
Q4
$319K Hold
1,000
0.03% 134
2017
Q3
$313K Hold
1,000
0.04% 131
2017
Q2
$271K Hold
1,000
0.03% 135
2017
Q1
$273K Hold
1,000
0.03% 133
2016
Q4
$284K Hold
1,000
0.03% 131
2016
Q3
$313K Hold
1,000
0.04% 126
2016
Q2
$242K Hold
1,000
0.03% 143
2016
Q1
$260K Hold
1,000
0.04% 142
2015
Q4
$306K Hold
1,000
0.04% 130
2015
Q3
$292K Hold
1,000
0.04% 129
2015
Q2
$404K Hold
1,000
0.05% 116
2015
Q1
$422K Hold
1,000
0.05% 115
2014
Q4
$339K Hold
1,000
0.04% 133
2014
Q3
$331K Hold
1,000
0.05% 117
2014
Q2
$315K Hold
1,000
0.05% 124
2014
Q1
$306K Hold
1,000
0.05% 132
2013
Q4
$280K Hold
1,000
0.04% 147
2013
Q3
$241K Sell
1,000
-109
-10% -$24.4K 0.04% 138
2013
Q2
$239K Buy
+1,109
New +$237K 0.05% 140

Other funds holding BIIB

Deroy & Devereaux Private Investment Counsel's BIIB Position: Q4 2020 in Review

Deroy & Devereaux Private Investment Counsel sold out of Biogen (BIIB) in Q4 2020, closing a stake of 875 shares — an estimated $248K sold.

Deroy & Devereaux Private Investment Counsel first reported a position in BIIB in Q2 2013 and held it in 30 quarters. The position peaked at $422K in Q1 2015. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Deroy & Devereaux Private Investment Counsel reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Deroy & Devereaux Private Investment Counsel sold 875 Biogen shares in Q4 2020, an estimated $248K.
  • Deroy & Devereaux Private Investment Counsel first reported a position in Biogen in Q2 2013 and held it in 30 quarters.
  • Deroy & Devereaux Private Investment Counsel's Biogen position peaked at $422K in Q1 2015.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q4 2020, filed 25 Jan 2021.